E-Mail
Registration
E-Learning
MS Teams
عربي
About ZU
About ZU
Welcome from the President
Vision & Mission
ZU Hierarchy
Rules and Regulations
Board of Trustees
Deans' Council
Doard of Directory Gate
ZU President
ZU Vice President
Councelors of the President
Admission
About Admission
Calender
Disciplines And Fees
Study Plans
Course Schedule
Level Exam
Evening Studies
Bachelor Degree Award Regulations
Master Degree Award Regulations
Admission Procedures
International Students
Average Calculator
Faculties
Shari'a
Arts
Economics and Administrative Sciences
Educational Sciences
Law
Arts and Design
Media
Dentistry
Pharmacy
Nursing
Allied Medical Sciences
Science
Information Technology
Engineering Technology
Graduate Studies
Deanships
Admission & Registration
Scientific Research
Students Affairs
Evening Studies
Library
Library in lines
Library Scheme
Departments
Library Search
Databases
E-Library
Centers
Computer Centre
E-Learning Center
Continuous Learning Center
Islamic Cultural Center
Energy Reearch Center
Administrative
Library
Development and Quality Assurance Unit
Directorate of Cultural and Public Relations
Directorate of Human Resources
Directorate of Financial
Directorate of Medical Services and Health Insurance
Directorate of Public Services and Maintenance
The International Relations Unit (IRU)
Zu Business Incupator
Portals
Registration
Email
Average Calculator
Staffs' Portal
Staff Directory
Employee Portal
بوابة نماذج الدراسات العليا
Scholarship Portal
Scientific Research Systemp Portal
Mahmoud A.Al-Sha'er
Pharmacy
Staff Information
Academic Rank
Full Professor
Minor
الكيمياء الطبية وتصميم الادوية واكتشافها
Office No
204 د
Phone
1409
Email
a.mahmoud@zu.edu.jo
CV
View File
Qualifications
Bachelor
BSc Phamacy
Date : 1998.02.08
Master
MSc pharmaceutical sciences
Date : 2000.06.30
Ph.D.
PhD Drug Design and Molecular Modeling
Date : 2010.06.19
Papers
Conferences
Experiences
Research Name
Date Of Publication
Discovery of novel potent nuclear factor kappa-B inhibitors (IKK-β) via extensive ligand-based modeling and virtual screening,
2017/03
Mutasem Taha
2018/02
Evaluation of Novel Akt1 Inhibitors as Anticancer Agents using Virtual Co-crystallized Pharmacophore Generation
2015/10
Discovery of Check Point Kinase1 (Chk1) Inhibitors as Potential Anticancer Agents Using Ligand-Based Modelling and Virtual Screening
2015/10
Screening of miscellaneous Hsp90 inhibitors using virtual co-crystallized pharmacophore
2015/10
Docking and pharmacophore mapping of halogenated pyridinium derivatives on heat shock protein 90
2015/04
Docking and pharmacophore mapping of halogenEvaluation of antimicrobial activities of synthesiz ed pyridinium derivatives
2014/09
Discovery of nanomolar Phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modelling and virtual screening followed by in vitro analysis
2014/07
Could the cancer be a chronic immune disorder? Rather than a serious malignant disease
2014/05
Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis
2014/01
Design, Synthesis and Biological Evaluation of N4-Sulfonamido-Succinamic, Phthalamic, Acrylic and Benzoyl Acetic Acid Derivatives as Potential DPP IV Inhibitors
2014/01
Evaluation of miscellaneous heat shock protein (Hsp90) inhibitors using different methodologies
2013/09
Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors
2013/03
1-[2-Substituted ethyl]-2-methyl-5-nitroimidazole derivatives, synthesis and antibacterial activities
2013/01
Journal Name
Session Place
Activity Name
Date
Associated Researcher
2020/02/11